During the past decade, CCOP - Central Illinois conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Central Illinois" #1 sponsor was "SWOG Cancer Research Network" with 56 trials, followed by "Radiation Therapy Oncology Group" with 32 trials sponsored, "Eastern Cooperative Oncology Group" with 21 trials sponsored, "Gynecologic Oncology Group" with 17 trials sponsored and "Wake Forest University Health Sciences" with 17 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Central Illinois" #1 collaborator was "National Cancer Institute (NCI)" with 159 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Central Illinois" are "Lung Cancer" (20 trials), "Breast Cancer" (17 trials), "Head and Neck Cancer" (14 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials) and "Prostate Cancer" (11 trials). Many other conditions were trialed in "CCOP - Central Illinois" in a lesser frequency.

Most popular intervention types in "CCOP - Central Illinois" are "Drug" (139 trials), "Radiation" (48 trials), "Procedure" (36 trials), "Biological" (34 trials) and "Dietary Supplement" (9 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (46 trials), "cisplatin" (26 trials), "paclitaxel" (21 trials), "carboplatin" (15 trials) and "cyclophosphamide" (13 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Central Illinois" are 113 trials for "All" genders, 41 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Central Illinois". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 143 completed trials in CCOP - Central Illinois, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Central Illinois, 10 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".